JavaScript is off. Please enable to view full site.

Vietnam receives 500,000 Sinopharm coronavirus vaccine doses from China

Vietnam receives 500,000 Sinopharm coronavirus vaccine doses from China

Sunday, June 20, 2021, 21:16 GMT+7
Vietnam receives 500,000 Sinopharm coronavirus vaccine doses from China
Containers of Sinopharm vaccine doses and other medical supplies lie beside a Vietnam Airlines plane at Noi Bai International Airport in Hanoi, June 20, 2021. Photo: Vietnam Airlines

A shipment of 500,000 Sinopharm coronavirus vaccine doses touched down in Hanoi on board a Vietnam Airlines aircraft on Sunday, adding to the country’s stock of AstraZeneca and Sputnik V jabs, according to the Ministry of Health.

The plane landed from Beijing at Noi Bai International Airport in the Vietnamese capital at 3:10 pm, the national carrier said in a statement.

The shipment also includes 502,400 syringes, the Ministry of Health added.

The Sinopharm vaccine shots, donated by China, will be used to immunize Chinese nationals in Vietnam, Vietnamese people who want to study or do business in China, and those who reside along the borders with China, the health ministry elaborated.

The ministry approved the jab for emergency use in Vietnam on June 3, following similar approvals for AstraZeneca, Sputnik V, and Pfizer vaccines.

The World Health Organization (WHO) listed the Sinopharm COVID-19 vaccine for emergency use on May 7, according to a news release posted on the global health agency’s website the same day.

The WHO had already given emergency use authorization to AstraZeneca, Johnson & Johnson, Pfizer, Moderna, and Sinovac vaccines.

More than 450 million Sinopharm doses have been supplied to over 70 countries and the COVAX vaccine-sharing scheme as yet, the health ministry said.

Vietnam has received nearly four million AstraZeneca shots from the COVAX scheme, direct purchase via a local company, and Japan, in addition to 2,000 Sputnik V jabs donated by Russia and 500,000 Sinopharm doses in the year to date.

The Vietnamese government has administered 2,359,376 AstraZeneca jabs to medical staff and other frontline workers since inoculation began on March 8.

It has given two doses to 115,315 people since.

Vietnam set a target of securing 150 million vaccine doses and inoculating two-thirds of its population of almost 98 million people this year.

So far the health ministry has recorded 13,211 patients, including 9,944 local infections since April 27, when the fourth and worst virus wave broke out in the country.

By comparison, Vietnam confirmed 106 community cases in the first wave from January 23 to April 16, 2020, 554 in the second from July 25 to December 1, 2020, and 910 in the third from January 28 to March 25, 2021. 

Recoveries have reached 5,229 while 66 patients have died, most with critical pre-existing medical conditions.

Like us on Facebook or follow us on Twitter to get the latest news about Vietnam!

Viet Toan / Tuoi Tre News


Read more




‘Taste of Australia’ gala dinner held in Ho Chi Minh City after 2-year hiatus

Taste of Australia Gala Reception has returned to the Park Hyatt Hotel in Ho Chi Minh City's District 1 after a two-year hiatus due to the COVID-19 pandemic

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Vietnamese youngster travels back in time with clay miniatures

Each work is a scene caught by Dung and kept in his memories through his journeys across Vietnam

Latest news

Fed minutes may shape debate over what follows June, July rate hikes

The Federal Reserve's May 3-4 policy meeting ended with a half-percentage-point rate increase and what Chair Jerome Powell has termed a 'broad sense' that similar increases would be approved when policymakers gathered in June and again in July to curb inflation that is far above the U.S. central bank's 2% target